Diabetic kidney disease (DKD) imposes a heavy medical burden worldwide due to the lack of effective treatment. High levels of mtROS and mitochondrial damage in the renal tubules are the initiating and ...

2023年美国肾脏病数据系统（USRDS）报告显示，糖尿病肾病（DKD）已成为亚太地区重大医疗负担。在亚太地区，DKD是导致肾衰竭（KF）患者需肾脏替代治疗（KRT）的主要病因，消耗大量医疗资源。自亚太肾脏病学会（APSN）在2020年发布关于糖尿病 ...

孙金鹏教授团队长期致力于膜受体GPCR相关研究，聚焦于GPCR的配体发现、药物靶点确证、功能研究和小分子确证，取得了系列原创性研究成果，相关成果在Nature（9篇）、Science（2篇）、Cell (4篇）等国际顶级期刊发表，并入选2023年中国十大科技进展及2023年度中国高等学校十大科技进展。

Which is more effective for preventing type 2 diabetes- metformin or lifestyle change? Long-term studies show lifestyle wins- ...

“Women with type 1 diabetes who have a history of hypertensive pregnancy are at greater risk for cardiovascular events later ...

Proteomics International is on the verge of releasing its groundbreaking PromarkerD diabetes blood test across the US, ahead ...

Diabetes is a leading cause of chronic kidney disease (CKD) worldwide, and with approximately 4.2 million South Africans ...

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction ...

BioCity is conducting initiate two Phase 3 trials: SUCCESS-01 (IgAN) and SUCCESS-02 (CKD). SUCCESS-01 has been launched at Guangdong Provincial People's Hospital, led by Professor Xueqing Yu, ...

The study looked at a drug called spironolactone. It’s normally used to treat high blood pressure, but it’s now showing ...

With its demonstrated clinical benefits and superior selectivity profile, SC0062 is positioned to potentially become a ...

Using a diabetic rat model, the researchers found that PEITC helped reduce or even reverse signs of kidney damage. This is ...